Viktoria Enkmann is CEO and co-founder of RNAnalytics, developing toolkits and software for LNP analytics in RNA therapeutics. With a background in biomedicine and analytical chemistry, she has over 10 years of industry experience. She previously held roles at Sciex and Vela Labs, focusing on CE and MS technologies. Viktoria holds an MBA and multiple science degrees. She is recognized for bridging lab innovation with scalable biotech solutions.